行情

VIVE

VIVE

Viveve Medical
NASDAQ

实时行情|Nasdaq Last Sale

0.5910
-0.0387
-6.15%
交易中 14:50 04/02 EDT
开盘
0.6460
昨收
0.6297
最高
0.6460
最低
0.5706
成交量
20.65万
成交额
--
52周最高
94.00
52周最低
0.5401
市值
592.65万
市盈率(TTM)
-0.0098
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测VIVE价格均价为4.000,最高价位4.000,最低价为4.000。

EPS

VIVE 新闻

更多
  • 瑞幸称相关人员已停职并被接任 有员工准备另谋出路
  • 新浪财经综合 · 1小时前
  • “大空头”查诺斯:需对因疫情短暂受益的“病毒股”保持谨慎
  • 新浪美股 · 2小时前
  • Recode:亚马逊禁止商家向公众销售N95和医用外科口罩
  • 新浪美股 · 2小时前
  • 你需要了解:新冠病毒将重铸美国科技版图
  • 新浪财经综合 · 2小时前

所属板块

先进医疗设备和技术
+2.39%
医疗设备和用品
+1.82%

热门股票

代码
价格
涨跌幅

VIVE 简况

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
展开

微牛提供Viveve Medical Inc(NASDAQ-VIVE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的VIVE股票新闻,以帮助您做出投资决策。